Vertiv’s AI Focus Outpaces Eaton’s Broader Power Play
Both companies are growing with data-center demand, but Vertiv’s faster organic sales growth comes with a more concentrated infrastructure bet.

Every Stocks story we have published, newest first.
78 stories in the last 24 hours
Updated 1:35 PM (Times shown in New York time (ET))
Page 15 of 25 · 584 stories
Both companies are growing with data-center demand, but Vertiv’s faster organic sales growth comes with a more concentrated infrastructure bet.

Baron increased its multifamily holdings, citing a better supply outlook and improving fundamentals in markets including San Francisco.

A repeat £342,000 medical-device order lifts the contract above £500,000 as the electronics maker pursues defence work and adds inspection equipment.

New and acquired products brought in $3.2 billion globally in the second quarter, as Pfizer steers resources toward growth areas.

Shares had more than doubled in 2026 as investors looked for evidence that AI identity products can drive durable growth.

A 24/7 Wall St. model sees further gains for Buffett’s longtime holding, backed by stronger sales and a higher 2026 earnings forecast.

Both steelmakers expect higher third-quarter earnings, but their forecasts fell short of Wall Street estimates after strong runs in their shares.

The Danish drugmaker promised new blockbuster medicines and expanded pill capacity, but investors wanted a clearer measure of growth before patents expire.

Strong sales and higher guidance fuel the recovery case, but some analysts question how much progress the share price already reflects.

Quest Diagnostics remains well ahead of the Nasdaq in 2026, though a new Medicare payment proposal sent shares lower.

Nine analysts raised MiniMed price targets after strong quarterly growth, but separation costs and a calendar boost complicate the cash-flow picture.

Workday surged 64% in three months, far ahead of software peers, though acquisition speculation and a weak year-to-date return complicate the picture.

VOO charges 0.03% annually and spreads exposure across large U.S. companies, but its history cannot predict how Anthropic shares will perform.

A steep share-price slide has brought Netflix’s forward earnings multiple down, but slowing sales growth and weaker engagement remain investor concerns.

The CNBC host cited Chili’s $10.99 meal deal and sales momentum, while Darden’s Olive Garden remained a key point to watch.

Shares hit a 52-week low as growth forecasts and cash reserves compete with rising incentives and a costly lending acquisition.

The used-car retailer says the cuts support a leaner workforce as CEO Keith Barr pursues $200 million in expense savings.

New controls for AI models and agents arrive as Fastly highlights security growth and rising machine-generated traffic to investors.

Record memory sales and long-term customer deals strengthen the case for Micron, but investors face a key test on September 30.

DIS is down more than 7% this year, while stronger quarterly profit and a lower valuation give investors reasons to keep watching.

A dozen analysts raised Samsara’s targets after strong results, while several kept neutral ratings as forecast growth slows from its latest pace.

ZBRA has surged in 2026 and outpaced the Dow over three months, but its one-year gain still falls short of the index.

Both oilfield-service companies are benefiting from stronger activity, but SLB has a wider set of growth drivers beyond drilling.

Rising gas costs are pushing up wholesale power prices, favoring some generators while leaving fuel-heavy and regulated businesses exposed.
